Recently, a more effective strategy for the treatment of T2DM has involved the disturbance of dietary monosaccharide absorption by inhibition of α-glucosidase [26], and PTP1B, which is involved in the dephosphorylation and inactivation of the insulin receptor, which attenuates insulin signaling. The gene discussed is PTPN1; the disease is type 2 diabetes mellitus.